Treating hypertension in type 2 diabetes

作者: Yoni Grossman , Gadi Shlomai , Ehud Grossman

DOI: 10.1517/14656566.2014.947267

关键词:

摘要: Introduction: The co-existence of hypertension and diabetes mellitus is very common. Hypertension remarkably increases the cardiovascular risk in diabetic patients. Lowering blood pressure (BP) these patients particularly beneficial.Areas covered: This paper will discuss what target BP for how that can be reached.Expert opinion: Previous guidelines recommended lowering < 130/80 mmHg However, recent studies did not support this accordingly most recommend to 140/90 Non-pharmacological approaches are all If levels above despite non-pharmacological treatment, drug therapy should initiated. Despite lack clear evidence, blockers renin–angiotensin–aldosterone system (RAAS) represent cornerstone antihypertensive arsenal; however, combination required. Combination RAAS blocker an...

参考文章(73)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
Ehud Grossman, Gadi Shlomai, Should we change the target blood pressure in diabetic patients Diabetes-metabolism Research and Reviews. ,vol. 28, pp. 1- 7 ,(2012) , 10.1002/DMRR.2348
Alan S. Go, Mary Ann Bauman, Sallyann M. Coleman King, Gregg C. Fonarow, Willie Lawrence, Kim A. Williams, Eduardo Sanchez, An Effective Approach to High Blood Pressure Control Journal of the American College of Cardiology. ,vol. 63, pp. 1230- 1238 ,(2014) , 10.1016/J.JACC.2013.11.007
Paolo Reboldi, Gentile, Angeli, Verdecchia, Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials Vascular Health and Risk Management. ,vol. 5, pp. 411- 427 ,(2009) , 10.2147/VHRM.S4235
T. Krause, K. Lovibond, M. Caulfield, T. McCormack, B. Williams, , Management of hypertension: summary of NICE guidance web science. ,vol. 343, pp. 365- 368 ,(2011) , 10.1136/BMJ.D4891
Anthony H. Barnett, Stephen C. Bain, Paul Bouter, Bengt Karlberg, Sten Madsbad, Jak Jervell, Jukka Mustonen, Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. The New England Journal of Medicine. ,vol. 351, pp. 1952- 1961 ,(2004) , 10.1056/NEJMOA042274